• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于联合强度矩阵的新型放射组学特征预测胶质母细胞瘤患者生存时间。

Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.

出版信息

IEEE J Biomed Health Inform. 2019 Mar;23(2):795-804. doi: 10.1109/JBHI.2018.2825027. Epub 2018 Apr 9.

DOI:10.1109/JBHI.2018.2825027
PMID:29993848
Abstract

This paper presents a novel set of image texture features generalizing standard grey-level co-occurrence matrices (GLCM) to multimodal image data through joint intensity matrices (JIMs). These are used to predict the survival of glioblastoma multiforme (GBM) patients from multimodal MRI data. The scans of 73 GBM patients from the Cancer Imaging Archive are used in our study. Necrosis, active tumor, and edema/invasion subregions of GBM phenotypes are segmented using the coregistration of contrast-enhanced T1-weighted (CE-T1) images and its corresponding fluid-attenuated inversion recovery (FLAIR) images. Texture features are then computed from the JIM of these GBM subregions and a random forest model is employed to classify patients into short or long survival groups. Our survival analysis identified JIM features in necrotic (e.g., entropy and inverse-variance) and edema (e.g., entropy and contrast) subregions that are moderately correlated with survival time (i.e., Spearman rank correlation of 0.35). Moreover, nine features were found to be associated with GBM survival with a Hazard-ratio range of 0.38-2.1 and a significance level of p < 0.05 following Holm-Bonferroni correction. These features also led to the highest accuracy in a univariate analysis for predicting the survival group of patients, with AUC values in the range of 68-70%. Considering multiple features for this task, JIM features led to significantly higher AUC values than those based on standard GLCMs and gene expression. Furthermore, an AUC of 77.56% with p = 0.003 was achieved when combining JIM, GLCM, and gene expression features into a single radiogenomic signature. In summary, our study demonstrated the usefulness of modeling the joint intensity characteristics of CE-T1 and FLAIR images for predicting the prognosis of patients with GBM.

摘要

本文提出了一套新的图像纹理特征,通过联合强度矩阵 (JIM) 将标准灰度共生矩阵 (GLCM) 推广到多模态图像数据。这些特征用于从多模态 MRI 数据中预测胶质母细胞瘤 (GBM) 患者的生存情况。我们的研究使用了来自癌症成像档案 (Cancer Imaging Archive) 的 73 名 GBM 患者的扫描数据。通过对比增强 T1 加权 (CE-T1) 图像与其对应的液体衰减反转恢复 (FLAIR) 图像的配准,对 GBM 表型的坏死、活跃肿瘤和水肿/侵袭亚区进行分割。然后从这些 GBM 亚区的 JIM 中计算纹理特征,并使用随机森林模型将患者分为短生存期或长生存期组。我们的生存分析确定了坏死 (例如,熵和逆方差) 和水肿 (例如,熵和对比度) 亚区的 JIM 特征与生存时间中度相关 (即,Spearman 秩相关系数为 0.35)。此外,还发现了 9 个与 GBM 生存相关的特征,其风险比范围为 0.38-2.1,经 Holm-Bonferroni 校正后,其显著性水平为 p < 0.05。这些特征在预测患者生存组的单变量分析中也具有最高的准确性,AUC 值在 68-70%之间。考虑到这项任务中的多个特征,JIM 特征导致的 AUC 值明显高于基于标准 GLCM 和基因表达的 AUC 值。此外,当将 JIM、GLCM 和基因表达特征组合成一个单一的放射基因组特征时,AUC 达到了 77.56%,p = 0.003。总之,我们的研究表明,对 CE-T1 和 FLAIR 图像的联合强度特征进行建模对于预测 GBM 患者的预后是有用的。

相似文献

1
Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.基于联合强度矩阵的新型放射组学特征预测胶质母细胞瘤患者生存时间。
IEEE J Biomed Health Inform. 2019 Mar;23(2):795-804. doi: 10.1109/JBHI.2018.2825027. Epub 2018 Apr 9.
2
Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.多尺度放射组学分析预测胶质母细胞瘤患者的生存情况。
Med Biol Eng Comput. 2018 Dec;56(12):2287-2300. doi: 10.1007/s11517-018-1858-4. Epub 2018 Jun 19.
3
A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.一项关于多形性胶质母细胞瘤表型形状描述符预测生存结果的定量研究。
Br J Radiol. 2016 Dec;89(1068):20160575. doi: 10.1259/bjr.20160575. Epub 2016 Oct 26.
4
Radiomic analysis of multi-contrast brain MRI for the prediction of survival in patients with glioblastoma multiforme.多模态脑MRI的影像组学分析用于预测多形性胶质母细胞瘤患者的生存期
Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:4035-4038. doi: 10.1109/EMBC.2016.7591612.
5
Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.评估肿瘤衍生的MRI纹理特征以鉴别胶质母细胞瘤的分子亚型并预测其12个月生存状态
Med Phys. 2015 Nov;42(11):6725-35. doi: 10.1118/1.4934373.
6
Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.用于 T1 加权和 T2-FLAIR MR 图像胶质母细胞瘤反应监测的稳健纹理特征:在识别和分割方面的初步研究。
Med Phys. 2010 Apr;37(4):1722-36. doi: 10.1118/1.3357289.
7
Extracted magnetic resonance texture features discriminate between phenotypes and are associated with overall survival in glioblastoma multiforme patients.提取的磁共振纹理特征可区分不同表型,并与多形性胶质母细胞瘤患者的总生存期相关。
Med Biol Eng Comput. 2016 Nov;54(11):1707-1718. doi: 10.1007/s11517-016-1461-5. Epub 2016 Mar 10.
8
Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.识别多形性胶质母细胞瘤的空间成像生物标志物以进行生存组预测。
J Magn Reson Imaging. 2017 Jul;46(1):115-123. doi: 10.1002/jmri.25497. Epub 2016 Sep 28.
9
Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.治疗前多参数磁共振成像中肿瘤周围脑实质的放射组学特征可预测胶质母细胞瘤的长期和短期生存:初步发现。
Eur Radiol. 2017 Oct;27(10):4188-4197. doi: 10.1007/s00330-016-4637-3. Epub 2016 Oct 24.
10
Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.放射组学分析揭示胶质母细胞瘤患者T1加权基线磁共振成像中的预后信息。
Invest Radiol. 2017 Jun;52(6):360-366. doi: 10.1097/RLI.0000000000000349.

引用本文的文献

1
A Radiomic Model for Gliomas Grade and Patient Survival Prediction.一种用于预测胶质瘤分级和患者生存情况的放射组学模型。
Bioengineering (Basel). 2025 Apr 24;12(5):450. doi: 10.3390/bioengineering12050450.
2
Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI.基于 MRI 的影像组学和视觉分析预测小鼠异位脑胶质瘤移植成功率。
J Neurooncol. 2024 Sep;169(2):257-267. doi: 10.1007/s11060-024-04725-z. Epub 2024 Jul 3.
3
Brain Tumor Recurrence vs. Radiation Necrosis Classification and Patient Survivability Prediction.
脑肿瘤复发与放射性坏死的分类及患者生存能力预测
IEEE J Biomed Health Inform. 2024 Oct;28(10):5685-5695. doi: 10.1109/JBHI.2024.3406256. Epub 2024 Oct 3.
4
Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.脑胶质瘤患者生存预后预测的 MRI 影像组学研究进展
Curr Oncol. 2024 Apr 14;31(4):2233-2243. doi: 10.3390/curroncol31040165.
5
Time-to-event overall survival prediction in glioblastoma multiforme patients using magnetic resonance imaging radiomics.使用磁共振成像放射组学预测多形性胶质母细胞瘤患者的生存时间。
Radiol Med. 2023 Dec;128(12):1521-1534. doi: 10.1007/s11547-023-01725-3. Epub 2023 Sep 26.
6
Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma.放化疗后早期异常信号体积演变对胶质母细胞瘤的预后和预测影响。
J Neurooncol. 2023 Apr;162(2):385-396. doi: 10.1007/s11060-023-04299-2. Epub 2023 Mar 29.
7
MR Intensity Normalization Methods Impact Sequence Specific Radiomics Prognostic Model Performance in Primary and Recurrent High-Grade Glioma.磁共振成像强度归一化方法对原发性和复发性高级别胶质瘤序列特异性影像组学预后模型性能的影响
Cancers (Basel). 2023 Feb 2;15(3):965. doi: 10.3390/cancers15030965.
8
MRI texture-based machine learning models for the evaluation of renal function on different segmentations: a proof-of-concept study.基于MRI纹理的机器学习模型在不同分割上对肾功能的评估:一项概念验证研究。
Insights Imaging. 2023 Feb 6;14(1):28. doi: 10.1186/s13244-023-01370-4.
9
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation.基于磁共振成像的放射组学用于指导胶质母细胞瘤的术后管理:对个性化放射治疗靶区勾画的意义
Front Med (Lausanne). 2023 Jan 19;10:1059712. doi: 10.3389/fmed.2023.1059712. eCollection 2023.
10
Current Evidence, Limitations and Future Challenges of Survival Prediction for Glioblastoma Based on Advanced Noninvasive Methods: A Narrative Review.基于先进无创方法的胶质母细胞瘤生存预测的现有证据、局限性和未来挑战:叙述性综述。
Medicina (Kaunas). 2022 Nov 29;58(12):1746. doi: 10.3390/medicina58121746.